可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Iyer SS,Pulskens WP,Sadler JJ,et al.Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome[J].Proc Natl Acad Sci U S A,2009,106(48):20388-20393.
[2]Martinon F,Burns K,Tschopp J.The inflammasome:a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta[J].Mol Cell,2002,10(2):417-426.
[3]Stutz A,Golenbock DT,Latz E.Inflammasomes:too big to miss[J].J Clin Invest,2009,119(12):3502-3511.
[4]Sandanger O,Ranheim T,Vinge LE,et al.The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury[J].Cardiovasc Res,2013,99(1):164-174.
[5]Nishiyama A,Matsui M,Iwata S,et al.Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression[J]. J Biol Chem,1999,274(31):21645-21650.
[6]Yoshioka J,Chutkow WA,Lee S,et al.Deletion of thioredoxin-interacting protein in mice impairs mitochondrial function but protects the myocardium from ischemia-reperfusion injury[J].J Clin Invest,2012,122(1):267-279.
[7]Zhou R,Tardivel A,Thorens B,et al.Thioredoxin-interacting protein links oxidative stress to inflammasome activation[J].Nat Immunol,2010,11(2):136-140.
[8]Mezzaroma E,Toldo S,Farkas D,et al.The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse[J].Proc Natl Acad Sci U S A,2011,108(49):19725-19730.
[9]Pober JS,Sessa WC.Evolving functions of endothelial cells in inflammation[J].Nat Rev Immunol,2007,7(10):803-815.
[10]Nishida M,Carley WW,Gerritsen ME,et al.Isolation and characterization of human and rat cardiac microvascular endothelial cells[J].Am J Physiol,1993,264(2 Pt 2):H639-H652.
[11]Arslan F,Smeets MB,O’ Neill LA,et al.Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody[J].Circulation,2010,121(1):80-90.
[12]Steffens S,Montecucco F,Mach F.The inflammatory response as a target to reduce myocardial ischaemia and reperfusion injury[J].Thromb Haemost,2009,102(2):240-247.
[13]Wanderer AA.Ischemic-reperfusion syndromes: biochemical and immunologic rationale for IL-1 targeted therapy[J].Clin Immunol,2008,128(2):127-132.
[14]Pomerantz BJ,Reznikov LL,Harken AH,et al.Inhibition of caspase 1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-1beta[J].Proc Natl Acad Sci U S A,2001,98(5):2871-2876.
[15]Menu P,Vince JE.The NLRP3 inflammasome in health and disease: the good, the bad and the ugly[J].Clin Exp Immunol,2011,166(1):1-15.
[16]Liu Y,Ma Y,Wang R,et al.Advanced glycation end products accelerate ischemia/reperfusion injury through receptor of advanced end product/nitrative thioredoxin inactivation in cardiac microvascular endothelial cells[J].Antioxid Redox Signal,2011,15(7):1769-1778.